ʻO ke Kemika Radical Māmā no ka hoʻololi ʻana i ka Peptide Late-Stage

Pane wikiwiki

Photoredox, PALEOLE, and C–H functionalization advances assessed for peptide-development feasibility: ka launa pū, haumia, hoʻonui, and analytical questions.

He aha ka manaʻo o "Milder" ma kēia ʻatikala

ʻoluʻolu, i ke kemika peptide, ʻaʻole ia he huaʻōlelo kūʻai. Hoʻopili ia i nā ʻāpana hana kikoʻī: pH 6–8, wela ≤ 37 °C, ʻōnaehana hoʻoheheʻe wai kūpono, a me ka hoʻomanawanui no ka hydroxyl, carboxyl, amino, thioether, imidazole, a me nā kaulahao ʻaoʻao guanidinium me ka pale ʻole. ʻO nā pae hoʻohālikelike i paʻi ʻia no ka hoʻohālikelike bioconjugation e wehewehe maʻamau i kēia pae, a ke hōʻike nui nei nā palapala kemika radical hou i nā hoʻokolohua i hana pololei ʻia i loko.

ʻO ke Kemika Radical Māmā no ka hoʻololi ʻana i ka Peptide Late-Stage

ʻŌlelo kēlā, Ua ʻokoʻa ka "māmā" i nā papa hoʻololi i wehewehe ʻia ma lalo nei. ʻO nā ala Photoredox me ka hoʻohana ʻana i nā photocatalysts organik a me nā LED uliuli a ʻōmaʻomaʻo paha e lilo i mea biocompatible ma ka paʻamau. Hiki i nā ʻano hana cascade e pili ana i ka HAT a me nā ʻano hoʻohui electrochemical C–H/S–H ke koi i nā mea hoʻohenehene. (ʻO ka maʻamau DMSO/hui wai) i nā lakio e pili ana i ka solubility o nā kaʻina hoʻohui lōʻihi a ʻoi aku paha. Ua kuhikuhi ʻia ʻo C(sp³)-H arylation ala - ʻoi aku ka palladium-catalyzed ʻano like ʻole - kau i nā kaohi hou aʻe e pili ana i ke kuhikuhi ʻana i ka hoʻonohonoho ʻana a me ka wehe ʻana., e hoʻohui i nā ʻanuʻu a me nā kumu haumia. ʻO ka nīnau no kēlā me kēia hui hoʻomohala ʻaʻole inā he "ʻoluʻolu ma ke kumu" ke ʻano akā inā he maʻalahi ia no ke kaʻina kikoʻī a me ka noi lalo..


Hoʻohui ʻia ʻo Photoredox: ʻO ka mea i kākoʻo ʻia e nā hōʻike

Ua hoʻokumu ʻo Photoredox catalysis i ke kino nui loa a hiki ke hana hou ʻia o ka ʻikepili hana peptide hope loa.. ʻO ka mīkini kumu - hoihoi i kahi photocatalyst me ka mālamalama ʻike ʻia, e hana ana i nā kikowaena radical reactive ma nā kūlana i wehewehe ʻia, a me ka hoʻohui ʻana iā lākou i nā mea ʻae a i ʻole nā ​​​​hoaaloha - hāʻawi i ka chemoselectivity ma o ke koho uila o ka mea hōʻeuʻeu-state catalyst ma mua o ka hoʻoikaika ʻana i ka hui..

ʻO ke Kemika Radical Māmā no ka hoʻololi ʻana i ka Peptide Late-Stage

ʻO Tryptophan ka mea hoʻohana mua. Ua hōʻike ʻia ʻo C2-alkylation a me C2-sulfenylation o tryptophan-containing peptides ma lalo o nā kūlana metala-free a me photocatalyst-free., ʻo ka mea hope e hoʻohana ana i nā paʻakai arylthianthrenium. A 2023 hōʻike i loko Palapala Organic (ACS, chemoselective hope-stage functionalization ma o photocatalytic C2-alkylation o tryptophan) i wehewehe ʻia i ka hoʻomanawanui pūʻulu hana kūpono me ka aspartate pale ʻole, glutamate, lysine, a me nā kaulahao ʻaoʻao serine - ʻo ia ka palena liʻiliʻi no ka hoʻokō ʻana i ka peptide hiki ke hoʻokō ʻia. A 2024 hoʻololi tryptophan clickable i wehewehe ʻia ma Nā holomua ʻepekema hōʻike ʻole ʻia ka catalyst-free, ʻO ka hopena hope loa o ka C2-sulfenylation e ʻae i nā koena cysteine ​​manuahi, he ho'āʻo koʻikoʻi o ka chemoselectivity.

Histidine alkylation. Ua hōʻike ʻia kahi alkylation Minisci-type C-H o ka histidine-containing peptides e hoʻohana ana i ka 4-alkyl-1,4-dihydropyridines ma ke ʻano he radical precursors.. He mea maʻamau ka Histidine i koena pilikia i nā pōʻaiapili kiʻi kiʻiʻoniʻoni ma muli o kona hiki ʻana i ka oxidation., no laila, hoʻohui ʻia nā ʻano hana i hoʻopaʻa ʻia i ke kūlana imidazole C2 a i ʻole C5 i kahi paʻa kemika.

Dehydroalanine (ʻO Dha) e like me ka versatile radical acceptor. Ua hoʻokomo ʻo Dha i ka enzymatically a i ʻole ma o ka hoʻololi kemika mai ka serine a i ʻole cysteine ​​e hana ma ke ʻano he Michael-type radical acceptor ma lalo o kahi ākea ākea.. A 2025 hōʻike ma ke kūkulu ʻia ʻana o nā glycopeptides pili i ka pūnaewele ma o ka photoredox catalysis (PubMed) ua hoʻohana ʻo Dha ma ke ʻano he ʻae no nā radical i loaʻa i ka N-glycosyl oxamic acid ma lalo o ke kukui ʻike ʻia, e hōʻike ana i ka hoʻohui ʻano Giese me ka pale ʻole i ke koena glycine, alanine, a i ʻole nā ​​koena serine. ʻO nā hua a me nā helu diastereoselectivity i kēlā noiʻi - a me ka loaʻa ʻole o kahi hopena stereoselective no nā hoʻohui radical Dha i nā hōʻike mua he nui - e hōʻike ana i kahi āpau mau.: ʻAʻole stereoretentive ka hoʻohui radical iā Dha, He mea nui ia i ka wā e hoʻopili ai ka hoʻonohonoho α-carbon i ka paʻa ʻana a i ʻole ke kūpaʻa protease.

Hoʻopili decarboxylative. Ua hōʻike ka hui o MacMillan e hiki ke koho ʻia ka carboxylate C-terminal o nā peptides a hoʻohui ʻia ma o ka decarboxylation radical ma lalo o ke kukui polū., ka hoʻohana ʻana i ka ʻokoʻa o ka hiki ke hoʻokahe ʻia ma waena o nā carboxylates kūloko a me terminal. Hoʻomaʻemaʻe ʻia kēia ala me ka mechanistically a pale i ka pale mua o nā kaulahao ʻaoʻao, akā, hoʻopau ia i ka C-terminus - e kaupalena ana i kona hoʻohana ʻana inā ʻaʻole hiki ke hoʻopau ʻia kahi kikowaena C manuahi a i ʻole ka pahu hopu ʻana..

Palapala hoʻomohala: Ua hōʻike nā ʻano Photoredox i ka ʻae ʻana o ka hui hana ākea ma waena o nā palapala. ʻO nā nīnau hāmama no ka hoʻohana ʻana i ka hoʻomohala ʻana he reagent a me ka wehe ʻana i ka photocatalyst, ka ʻike o ka oxygen i ka wā o ka hana a me ka hana, a inā paha nā ʻōnaehana solvent (pinepine DMSO/wai) kūpono me ka hoʻomaʻemaʻe ʻana i lalo a me ka lyophilization me ka hoʻokomo ʻole ʻana i nā koena hoʻomau.


HAT a me MHAT: Ho'ōla mamao me ka hana mua ʻole

Hoʻoili ʻātoma hydrogen (PALEOLE) Noho kemika i kahi niche ʻokoʻa mai photoredox. Ma mua o ka huli ʻana i kahi lima redox-active i koho mua ʻia, ʻO nā ala HAT-based abstract hydrogen atoms mai C(sp³)-H nā paʻa e hana i nā radical i hoʻokumu ʻia i ke kalapona i nā kūlana e pono ai ke alakaʻi i nā hui a i ʻole prefunctionalization.. I ka pōʻaiapili o ka hoʻololi peptide, ʻelua mau mea kēia: ka hana mamao ma o 1,5-HAT relay kaʻina hana a me ka sequential cascade reactions e hui pū ana i ka radical generation me ka lua o ka catalytic bond-forming step..

Hoʻohuihui Peptide A 2025 pepa i loko Nā Kūlana Kemika Organic (RSC, ʻekolu-hui alkylation o nā glycine derivatives a me nā peptides ma o ka pae-koho 1,5-HAT cascade) hōʻike i ka ʻike-māmā-mediated N-centered radical generation a ukali ʻia e ka 1,5-hydrogen atom transfer i ka α-carbon o nā koena glycine, hiki i ka alkylation ekolu. Aia ke koho mai ka geometry o ka 1,5-shift ma mua o ka makemake uila no kekahi kaulahao ʻaoʻao., nona nā pono a me nā palena: pili nui ke ala i nā kaʻina glycine akā ʻaʻole i ʻike maoli i waena o nā koena i hoʻonohonoho like ʻia i nā kaulahao lōʻihi..

HAT kokua metala, ʻōlelo ʻia i kekahi manawa ma kāna cobalt- a i ʻole nā ​​mea i hoʻopili ʻia me ka hao e like me MHAT, lawe mai i ka mana hou. Hoʻopuka ka hydride metala i kahi kalapona kalapona ma lalo o nā kūlana haʻahaʻa - ʻo ka maʻamau o ka lumi wela, hydrogen a i ʻole silane ma ke ʻano he kumu hydrogen - a hiki ke hoʻopaʻa ʻia ka radical e ka alkene a i ʻole ka mea ʻae radical i loko o ka ipu hoʻokahi.. No ka noi peptide, ʻO ka nīnau pili inā pili ka mea hoʻoheheʻe metala a me ke kumu hoʻohālikelike hydrogen me ka histidine, methionine, a me nā kaulahao ʻaoʻao cysteine, ʻo ia mau mea a pau he mau hoa hoʻokūkū hoʻokūkū. Loaʻa ka mua i paʻi ʻia no nā substrate dipeptide maʻalahi a me ka tripeptide; ʻO ka hōʻoia ʻana i ka lōʻihi o ke kaulahao lōʻihi me nā kaulahao ʻaoʻao ʻaoʻao he nui i kaupalena ʻia i nā puke mua ma waena o 2026..

Palapala hoʻomohala: He nani nā ʻano HAT a me MHAT no ka hoʻololi ʻana i nā kaʻina kahi e paʻa ai ka radical kūlohelohe (Cys, Trp, ʻO Dha) ʻaʻole i loaʻa a pono e mālama ʻia no ka hana olaola. He ʻoiaʻiʻo ka paʻakikī koho koho pūnaewele - he peptide pōkole kahi e nānā maikaʻi ai ke koho ʻana i ʻokoʻa ke ʻano ma kahi kaʻina 20-koe me nā kūlana abstractable hoʻokūkū..


C(sp³)–H Hoohana: Hoʻoponopono i ka iwi kuamoʻo-pili

Ua kuhikuhi ʻia ʻo C(sp³)-H ka hana ʻana i ka lima ʻoi loa o kēia kemika no nā noi peptide, ke kāʻei ʻana i nā kūlana i loko o ka iwi kuamoʻo-kokoke me ka ʻole o ka lima hana kuʻuna. Ua hōʻike ʻia nā ala ʻelua i ka hiki ke hoʻomākaukau ʻia i nā substrates peptide.

ʻO ka arilation ʻaoʻao-chain-directed. A 2024 aʻo mai Hou et al. - i hōʻuluʻulu ʻia ma kahi 2026 Nānā RSC (nā holomua hou i nā hoʻololi kikoʻī kikoʻī o nā peptides a me nā protein) - hōʻike ʻia ʻo β-C(sp³)-H arylation o nā kūlana kūloko i nā peptides linear a me cyclic e hoʻohana ana i ka S-alkyl cysteine ​​​​ma ke ʻano he alakaʻi a me 2-pyridone ma ke ʻano he ligand kōkua., ma lalo o ka palladium catalysis. Ua loaʻa i ke ala ka hoʻoulu ʻana ma ka β-carbon o ke koena e pili ana i ka pūʻulu kuhikuhi i loaʻa i ka cysteine ​​ma lalo o nā kūlana haʻahaʻa loa no ka hoʻoulu ʻana o ka palladium-catalyzed C-H..

Nā hui kuhikuhi i hoʻokomo ʻia i ka iwi kuamoʻo. A 2025 hōʻike i loko JACKS (PubMed, Pd(II)-hoʻopaʻa ʻia C(sp³)-H functionalization kuhikuhi ʻia e kahi removable, iwi kuamoʻo-hoʻokomo ʻia ʻo amidoxime ether) wehewehe ʻia ka hoʻokomo ʻana o ka eter amidoxime ma kekahi paʻa amide ma ka iwi kuamoʻo, e hoʻohana ana iā ia ma ke ʻano he hui alakaʻi hiki ke hoʻoneʻe ʻia no C ma hope(sp³)–H ka hoolaha. Hoʻokomo ʻia ka ether amidoxime a wehe ʻia i nā ʻanuʻu synthetic kaʻawale, hoʻohui i ʻelua mau hoʻololi i ke ala - akā ʻo ka hiki ke hoʻololi i ke kūlana i hāʻawi ʻia ʻaʻohe mea like i nā ala hoʻololi maʻamau o kēia manawa.

No ka hoʻonohonoho ʻana-agnostic, He mea nui kemika kēia papa. ʻO ke kaumaha kūpono - ka wehe ʻana i ka palladium, e kuhikuhi ana i ka hoʻokomo a me ka wehe ʻana o ka hui, ʻO ka hui pūʻulu palekana SPPS kūpono, a me ka epimerization hiki i ka α-carbon ma lalo o ka palladium catalysis - ʻo ia ka mea kaumaha loa ma waena o nā ʻohana hoʻololi ʻekolu i kūkākūkā ʻia ma aneʻi..


Nā ʻano hana ʻino ma muli o ka Sulfur: Kākoʻo ʻia ʻo Chemoselectivity e ka ʻikepili

Noho ʻo Cysteine ​​​​ke koena hiki ke nānā ʻia no ka hoʻololi ʻana i ka peptide koho i ka pūnaewele no ka mea ʻokoʻa loa kona nucleophilicity sulfur a me redox chemistry mai nā kaulahao ʻaoʻao ʻē aʻe e ʻae i nā hopena maʻemaʻe me nā kumu radical electrophilic kūpono.. Nui nā hōʻike 2024–2025 e hoʻonui i kēia pahu hana i nā kuhikuhi pili i nā papahana conjugation.

Ua hōʻike ʻia nā radical Aryl i hana ʻia mai nā aryl pinacol boronates ma lalo o nā ʻano wai ʻoluʻolu e hana i ka S-arylation koho o nā peptides a me nā protein. (aril radicals mai aryl pinacol boronates no ka peptide a me ka hoʻololi protein, TU Darmstadt/Wiley). ʻO ke koho ʻana no ka sulfur ma luna o nā kaulahao ʻaoʻao amino acid ma lalo o ka wai, ʻO nā kūlana kokoke-kūʻokoʻa e hōʻike ana i kahi holomua kūpono ma mua o ka kemika paʻakai aril diazonium, i emi loa ke koho.

ʻO kahi ala electrochemical i ka C-H/S-H cross-coupling no nā peptides i loko o ka cysteine., me ka macrocyclization intramolecular, ua wehewehe ʻia ma Nature Communications (electro-induced C–H/S–H cross-coupling no ka functionalization/macrocyclization o ka cysteine-containing peptides, 2025). ʻO ka hoʻolālā umpolung - e hana ana i kahi thiyl radical electrochemically a hoʻopili iā ia i kahi paʻa C-H pili - e hana me ka ʻole o ka oxidant o waho a i ʻole photocatalyst a ʻae i ka nui o nā kaulahao ʻaoʻao..

No nā polokalamu e pili ana i nā peptides stapled, ADC-like conjugation, a i ʻole ka hōʻailona fluorescence ma nā kūlana i wehewehe ʻia, ʻO kēia mau ala koho sulfur e hōʻike ana i ka helu helu haʻahaʻa haʻahaʻa loa no ka mea aia ka ʻikepili chemoselectivity ma waena o nā kaulahao lōʻihi loa i hōʻoia ʻia a me nā kaiapuni ʻaoʻao ʻaoʻao like ʻole..


Hoʻolikelike, haumia, a me na Nīnau Analytical Pono e pane

ʻO ke kemika i hōʻike ʻia ma luna nei he ʻoiaʻiʻo a hiki ke hana hou ʻia ma ka pae ʻike. Pono ka unuhi ʻana i ka pālākiō hoʻomākaukau a me ka hoʻomohala ʻana i nā pane pololei i nā ʻano nīnau ʻehā ma mua o ke komo ʻana o kekahi o kēia mau ala i kahi kaila hana hoʻomohala maʻamau..

Ka Hoʻohālikelike Hoʻohālikelike

Ma mua o ka hana ʻana i kahi ala hoʻololi radical hope loa, Pono nā hui hoʻomohala e palapala i kēia mau mea:

Anana kūpono

He aha ka mea e hoʻoholo ai

No ke aha ia mea

ʻO ka hoʻomanawanui ʻana o ka solvent o ke kaʻina

Hiki ke hoʻoheheʻe ʻia ka peptide i ka DMSO/wai a i ʻole nā ​​kūlana DMSO-free pono?

Nui nā ala radical e makemake i nā ʻōnaehana DMSO; Hiki ke hoʻoheheʻe ʻia nā kaʻina aggregation-prone a hydrophobic

Nā hopena hoʻokūkū ʻaoʻao

Owai na kaulahao aoao (Met, Trp, ʻO Tyr, ʻO kāna, Cys inā ʻaʻole ka pahuhopu) hiki ke hana ma lalo o nā kūlana i koho ʻia?

Hiki ke hōʻike ʻia kahi ʻano hana i hoʻopaʻa ʻia ma kahi peptide hoʻohālike maʻalahi i nā pilikia koho hou i kahi kaʻina me nā koena koʻikoʻi he nui.

Paʻa a me ka ʻike pH o ka photocatalyst a i ʻole radical precursor

Hana i nā mea hoʻohui (ʻakika, kumu, hoemi) hoʻohaʻahaʻa ʻO nā Peptides Synthetic ka iwi kuamoʻo peptide a i ʻole nā ​​koena kikoʻī?

Hiki i nā kūlana haʻahaʻa ke hoʻolalelale i ka asparagine deamidation, aspartate isomerization, a i ʻole N→O acyl hoʻoili i ka serine i nā manawa hoʻopaneʻe lōʻihi

ʻO ka ʻike o ka oxygen

Pono ke ala i ka lewa inert ma ka pae ʻike? Hana ʻia ʻo Peptide

ʻO ka ʻike o ka oxygen i hiki ke mālama ʻia i loko o kahi hue aniani liʻiliʻi e lilo i mea hoʻolālā reactor a me ka nīnau ʻōnaehana maikaʻi ma ka pae hoʻomākaukau.

Wehewehe Huapalapala

Hoʻokomo ka hoʻololi radical hope i kahi papa o nā haumia ʻokoʻa mai nā mea haumia i loaʻa mai SPPS. Manaʻo a hoʻolālā i nā ʻano analytical no:

  • Mea hoʻomaka ʻaʻole i hana ʻia: unconjugated peptide co-eluting me a kokoke paha i ka huahana

  • ʻOi aku ka hoʻololi ʻia: inā ʻoi aku ma mua o hoʻokahi paena reactive (e.g., ʻelua koena tryptophan), E ʻike ʻia nā huahana hoʻololi he nui ma ke ʻano he mau hōʻailona kiʻekiʻe ma ESI-MS a i ʻole MALDI-TOF

  • Nā huahana Regioisomeric: no ka hoʻohui radical Dha a i ʻole histidine alkylation, ʻO nā isomers kūlana i ʻokoʻa wale nō ma ka pūnaewele o ka hoʻokumu ʻana i ka paʻa hiki ke ʻike ʻole ʻia e RP-HPLC wale nō.

  • ʻO nā huahana oxidation: Hiki i nā kūlana radical ke hoʻoheheʻe i ka methionine i ka sulfoxide a i ʻole tryptophan i ka oxindole - nā piko e pili kokoke ana i ka mea hoʻomaka ma ka reverse-phase chromatography.

  • Nā mea hoʻohui i loaʻa i ka Catalyst: nā ʻāpana photocatalyst organik, koena palladium (no ka hana C–H), a i ʻole nā ​​​​huahana hou mai ka HAT co-reagents e hana i nā mea hoʻohui me ka peptide

Hoʻopili ka hoʻoponopono a me ka CMC i kēia ʻāina haumia me ka EMA ʻO ke alakaʻi no ka hoʻomohala ʻana a me ka hana ʻana i nā peptides synthetic, e kamaʻilio pololei ana i nā reagents kaʻina, mea haumia, a me ka hoʻolālā hoʻomalu no nā intermediates synthetic.

Koi Analytical

RP-HPLC maʻamau ma 214 nm, e hana maikaʻi ana no ka hoʻolaha ʻana i ka haumia SPPS, ʻaʻole lawa no nā puka hoʻololi hoʻololi hope. Pono nā hui e hoʻolālā:

  • LC-MS a i ʻole LC-HRMS ma ke ʻano he mea hana mua - pono ʻo MS e hoʻokaʻawale i nā mea hoʻomaka unconjugated mai ka huahana mono-modified inā loaʻa iā lākou ka paʻa chromatographic like.

  • Nā ʻano ʻano chromatography orthogonal (e.g., HILIC a i ʻole IEX ma kahi o RP) ke manaʻo ʻia nā regioisomers; ʻAʻole e hoʻonā ʻia nā regioisomers me ka nuipaʻa like me ka ʻike lehulehu wale

  • Ka nānā ʻana i ka ʻakika amino (AAA) no ka hōʻoia ʻana i ka hui ʻana o ka waikawa amino ma hope o ka hoʻololi ʻana e kūlike me kahi hanana hoʻohui hoʻokahi, ʻaʻole ka ʻoki iwi kuamoʻo a i ʻole ka nalowale o ke kaulahao ʻaoʻao maʻamau

  • Nā ʻano hana hoʻopaʻa paʻa hiki ke hoʻokaʻawale i nā haumia synthesis (aia ma ka pūʻulu mua) mai nā huahana hoʻohaʻahaʻa i ʻike ʻia i ka wā lōʻihi - koʻikoʻi i ka wā e hoʻolauna ai kahi hana hoʻololi radical i nā chromophores hou a i ʻole nā ​​​​hui hana e hoʻololi i ka ʻike paʻa o ka oxidation a i ʻole hydrolysis o ka peptide.

ʻEnekinia Hoʻonui

Hōʻike nā ʻano hana Photoredox i nā luʻina kikoʻī kikoʻī kikoʻī no ka mea ʻaʻole i hoʻohālikelike ʻia ka lawe ʻana i ka photon. ʻO ka māmā māmā i hana ʻia ma ke kikowaena o ka pahu 1-lita he hapa ia o kēlā ma ka ʻili o ka moku, a ʻo ka hoʻololi ʻana i ka hoʻololi ʻana o ka lamp-to-reactor geometry ma ke ʻano ʻaʻohe analogue i ke kemika hoʻokele thermally. Hoʻolālā ʻia nā reactors kemika kahe no ka photocatalysis e hoʻoponopono i kēia ma o ka kiʻiʻoniʻoni ʻoniʻoni a i ʻole ka kahe-ma o ka irradiation., a aia kekahi mau hoʻolālā reactor i hoʻopaʻa ʻia i kēia manawa no ka hoʻomohala ʻana i ke kaʻina hana lāʻau lapaʻau - akā pono lākou i ke kapena mua a me ke ʻano hoʻoponopono hou i kēlā me kēia pae pae..

Loaʻa i nā HAT a me nā ʻano electrochemical nā ʻano kikoʻī hoʻonui. ʻOi aku ka wānana ʻana o nā unahi ʻili uila ma mua o ka lawe ʻana i ka photon, akā, hoʻokomo nā ʻano electrochemical i nā nīnau e pili ana i ka hoʻohālikelike ʻana o nā mea electrode, hoʻoneʻe electrolyte, a me ka like like o kēia manawa ma ka pālākiō hoʻomākaukau.

No nā papa hoʻololi a pau, ʻo ka hoʻololi ʻana mai ka hoʻomaʻemaʻe HPLC analytical-scale i ka HPLC hoʻomākaukau e hoʻolauna i nā pilikia hoʻonā hou. A late-stage modification product co-eluting with mono-modified regioisomers at analytical scale will require careful re-optimization of gradient slope, haku mele ʻana, and column chemistry at preparative loading — and preparative HPLC recovery from a complex mixture is the rate-limiting step in peptide scale-up more often than the synthesis itself.


He Kūlana no ka loiloi ʻana i ka hiki ke hoʻokō

Rather than adopting any of these methods wholesale, development teams should run a structured feasibility assessment tied to the specific modification target. The following decision matrix reflects the compatibility and risk dimensions discussed above.

Assessment question

Low-risk signal

Pause signal

Does the target residue exist as a single unique copy in the sequence?

ʻAe, with no structurally similar competing residue

Multiple potential sites of the same type

Ua kūpono ka paena hoʻololi me nā ʻōnaehana DMSO wai?

Hiki ke hoʻoheheʻe ʻia ke kaʻina a me ka hui ʻole i DMSO/H₂O

ʻO ke kaʻina hydrophobic me ka hōʻuluʻulu ʻana i kākau ʻia i nā mea hoʻoheheʻe hui ʻia

Hiki ke hoʻoneʻe ʻia nā koena catalyst a i ʻole reagent e nā ala RP-HPLC?

ʻAe, a i ʻole ma mua o ka palapala

ʻAʻohe kumu hoʻohālikelike; ʻaʻole maopopo ka hoʻokumu ʻana o nā mea hou

ʻAʻole ʻae ka noi i lalo i ka pilikia racemization?

ʻAe ʻia nā diastereomers ma ke kahua hoʻololi

Pono ka hoʻonohonoho α-carbon pololei ma ke koena i hoʻololi ʻia

Ua kūpono ka pane ʻana me ka lewa inert ma ka pālākiō i koho ʻia?

ʻAe, a i ʻole ka loaʻa ʻana o nā ʻōnaehana kemika kahe

Pono ke kemika moku hāmama ma ka pālākiō multi-gram me ka ʻole o ka hopena reactor i wehewehe ʻia

ʻAʻole e hōʻoiaʻiʻo ʻia ka holomua o ka holo ʻana i ka papa inoa piha - akā ʻike ia i nā hoʻokolohua e hoʻomaka mua ma mua o ka hana ʻana i nā kumuwaiwai hoʻomohala.. ʻO ka pale kūpono ʻole ma ka pālākiō 5-milligram e mālama i ka manawa ʻoi aku ka nui ma mua o ka hāʻule like ʻole ma 100 milligrams i ka wā o ka holo ʻana o ka CRO.


Ma kahi i loaʻa ai nā kahua hoʻohui i hiki ke kōkua

Nā papahana e loiloi ana i kēia mau ʻano hou me nā mea i loaʻa, ʻO nā ala hoʻololi i hōʻoia ʻia e kuhikuhi maoli i ka mea e hiki ai i kā lākou hoa hana synthesis ke hoʻokō me ka ʻole o kahi kaʻina hana maʻamau. Nā paepae hoʻololi peptide ʻo ia ka mea maʻamau e mālama i nā kaomi kemika (azides, ma ka chess, nā ʻalekina), hoʻokomo glycopeptide, a ka hoʻopili ʻana i ka lepili fluorescent a i ʻole isotope ke hana nei i loko o ka envelope hoʻomanawanui pūʻulu hana e hoʻonui nei nā ʻano hana hope loa.

ʻO ka waiwai o nā ʻano radical hou ʻaʻole ia e hoʻololi i kēia mau ala conjugation i hoʻokumu ʻia - ʻo ia ke kiʻi ʻana i nā kūlana hoʻololi i hiki ʻole i nā kemika kahiko ke hiki., ʻo nā kūlana iwi kuamoʻo o loko a me nā koena i nele i nā lima nucleophilic kūpono. I ka hiki ana i ka bottleneck, ʻO kahi ala hana radical i manaʻo ʻia e kūpono i ka hoʻopukapuka hoʻomohala ʻana a me ke kaʻina hana.

No nā mea a pau, hoʻokumu ʻia hana peptide maʻamau ʻO nā kaʻina hana me nā pae hoʻohālikelike i wehewehe ʻia i ka haumia a me nā pūʻolo analytical hōʻoia ʻia ke ala wikiwiki loa i kahi QC-hoʻokuʻu ʻia., pūʻulu mākaukau hoʻomohala.


Nā Nīnau ʻAʻole i pane ʻia ke kahua

E hoʻopau me kahi waihona waiwai pono: ua hoʻokumu ka palapala 2024-2025 e hana ana ke kemika radical māmā i nā peptides ma lalo o nā kūlana ʻike.. ʻAʻole i hoʻokumu ʻia, no ka nui o na ala:

  1. Scalability: pehea ka huli ʻana a me ke koho ʻana 100 milligrams kūʻē 1 gram kūʻē 100 nā grams ma lalo o nā kūlana kaʻina hana maoli, me ka wehe ʻana o ka oxygen kūpono a me ka mālama ʻana i ka mahana

  2. Stereoselectivity ma Dha: ʻO ka hoʻohui radical i ka dehydroalanine e hoʻopuka i kahi kikowaena α hou me ka ratio diastereomeric variable; he pilikia hamama keia, a me ka mea hou ChemBioChem loiloi (holomua i ka hoʻololi kikoʻī dehydroalanine, 2025) hōʻike pololei ʻia ʻo ia ʻaʻole i hoʻoholo ʻia no ka hapa nui o nā papa substrate

  3. Kūlana hoʻoponopono: ʻaʻohe o kēia mau alahele, i ka ike lehulehu, ʻo ia ke kumuhana o kahi ʻāpana CMC IND e uhi ana i ka pono haumia, ka loiloi haumia genotoxic o nā koena photocatalyst, a i ʻole ka hōʻoia ʻana i ke ʻano hōʻoia no ka API i hoʻololi hou ʻia - ke waiho ʻia ke kumu

  4. Paʻa lōʻihi o ka paʻa hoʻololi: nā hoʻohui radical iā Dha, Trp, a me kana hana C–C, C–S, a i ʻole nā ​​paʻa C–N me nā ʻano paʻa like ʻole; ʻAʻole liʻiliʻi ka ʻikepili haʻawina paʻa no ka hapa nui o nā conjugates

ʻAʻole kēia nā kumu e hoʻopau ai i ka kemika. ʻO lākou ka papahana hoʻokolohua a me ka hoʻoponopono e pono e hoʻolālā ʻia me nā hoʻoholo e hoʻohui i kēia mau ʻano i loko o kahi kaila hana hoʻomohala lapaʻau..


Nā ʻanuʻu aʻe no nā Pūʻulu Hoʻomohala

No nā pūʻulu e loiloi ikaika ana inā pili ka hana hoʻokō ʻana i ka hana hope loa i kā lākou hoʻolālā hoʻololi, ʻO nā hana hoʻohua kokoke loa:

  • Kōmike i ka holo liʻiliʻi (5–10 mg) me ke kaʻina pololei, ka huli ʻana i ke ʻano koena kikoʻī, ma lalo o nā kūlana radical i manaʻo ʻia - me ke ʻano LC-HRMS o ka hui ʻana, ʻaʻole wale ka maʻemaʻe HPLC

  • E noi i ka ʻikepili kūpaʻa ma ka hoʻopaʻa hoʻohui radical ma lalo o ka pH extremes, kaumaha oxidative, a me ke kaumaha wela ma mua o ka hoʻolālā ʻana i ke ʻano hoʻomaʻemaʻe

  • Palapala ʻāina i ka moʻolelo haumia o ka pala e kūʻē i ka mea hiki i kāu ʻōnaehana HPLC hoʻomākaukau ke hoʻoholo, ka hoʻohana ʻana i nā maʻamau kuhikuhi spiked inā loaʻa

  • E ʻike inā loaʻa ka ʻōlelo hoʻoponopono no ka catalyst a i ʻole ka papa reagent ma nā hōʻuluʻulu IND CMC i paʻi ʻia., Nā palapala alakaʻi FDA, a i ʻole nā ​​hōʻike loiloi EMA

Ke neʻe wikiwiki nei ka kemika. ʻO ka hoʻomohala ʻana a me ke kaʻina hana e hoʻohana pono ai i kahi papahana hoʻomohala ʻoi aku ka lōʻihi o ke kūkulu ʻana. E hoʻomaka ana kēlā hana i kēia manawa, ma ke kaʻina pahuhopu i wehewehe maikaʻi ʻia, ʻo ke ala kūpono.


MOL Changes kākoʻo i nā hui hoʻomohala e hoʻokele ana i nā koi hoʻololi paʻakikī ma waena o nā mea ʻoi aku 300 ʻano hoʻololi pūʻulu hana, me ka kaomi ʻana i ke kemika conjugation, ka hana ʻana o ka glycopeptide, a me ka hana peptide i hoʻopaʻa ʻia i ka isotope i loko o kahi Papa 100 wahi hana sterile. Inā pili kāu polokalamu i nā kūlana hoʻololi a i ʻole nā ​​pahuhopu conjugation e hāʻule i waho o nā kahe hana SPPS maʻamau, ʻO ke kūkākūkā kūpono ʻenehana he wahi hoʻomaka kūpono.

Xiaoxia Chen

Xiaoxia Chen

Laau Laau Hou R&D ʻenehana Kaʻike kumu: Loaʻa ka pahuhopu, pilina hana-hana (SAR) kālailai, peptide-lāʻau conjugates (Nā PDC), a me ka hoʻomohala ʻana i nā peptides anti-kahiko a me ka metabolic.

Pilikino: Ua alakaʻi ʻo Xiaoxia Chen i ka ʻike mua ʻana a me ka noiʻi preclinical no kekahi mau lāʻau peptide metabolic a me ka tumor-targeted.. ʻAʻole wale ʻo ia i mākaukau i ka nānā ʻana i nā hale waihona puke peptide, akā akamai nō hoʻi i ka hoʻohana ʻana i ka biology computational kōkua AI no ka hoʻolālā ʻana o ka de novo peptide sequence.. I kēia manawa, ke alakaʻi nei ʻo ia i kahi hui i hoʻolaʻa ʻia i ka noiʻi hohonu a me ka hoʻomohala ʻana o nā agonists multifunctional hanauna hou (like me pālua- a i ʻole nā ​​peptides hoʻohaʻahaʻa momona ʻekolu) a me nā peptides hoʻoponopono hou i ke kino.

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana